Adjuvant antibody therapy with trastuzumab in early breast cancer

被引：0
|
作者：
Untch, Michael
Scharl, Anton
Jackisch, Christian
Thomssen, Christoph
Nitz, Ulrike
von Minckwitz, Gunter
Harbeck, Nadia
机构：
[1] Univ Charite, Akad LK, Helios Klinikum Berlin Buch, Frauenklin,Interdisziplinaires Brustzentrum, D-13125 Berlin, Germany
[2] Frauenklin Amberg, Amberg, Germany
[3] Frauenklin Offenbach, Offenbach, Germany
[4] Univ Halle Wittenberg, Frauenklin, D-4010 Halle, Germany
[5] Univ Dusseldorf, Frauenklin, D-4000 Dusseldorf, Germany
[6] GBG Forsch GmbH, Neu Isenburg, Germany
[7] Tech Univ Munich, Frauenklin, D-8000 Munich, Germany
来源：
BREAST CARE | 2006年 / 1卷 / 04期
关键词：
HER2/neu; monoclonal antibody; breast cancer; trastuzumab; adjuvant therapy;
D O I：
10.1159/000094891
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Immunotherapy with the monoclonal antibody trastuzumab is a well established cornerstone of an individualized treatment strategy for women with HER2/neu-over-expressing breast cancer. Based on the reported data of clinical studies comprising more than 14,000 women, trastuzumab was approved throughout the European Union in May 2006 for adjuvant therapy in patients with early-stage HER2/neu-overexpressing breast cancer.
引用
收藏
页码：252 / 255
页数：4
相关论文
共 50 条
  • [1] Antibody therapy for early-stage breast cancer: trastuzumab adjuvant and neoadjuvant trials
    Mehra, Ranee
    Burtness, Barbara
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (09) : 951 - 962
  • [2] Adjuvant trastuzumab in early breast cancer
    Mariani, G.
    Gianni, L.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : X54 - X58
  • [3] Cost-effectiveness analysis of adjuvant therapy with trastuzumab for early breast cancer
    Wardley, Andrew M.
    Cameron, David A.
    Bell, Richard
    Erny, Samuel
    Cohen, Carole
    Geary, Una
    Walzer, Stefan
    Gyldmark, Marlene
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 95 - 96
  • [4] Trastuzumab Therapy for Early Breast Cancer
    Charbonneau, Flay
    [J]. CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2006, 59 : 41 - 42
  • [5] Adjuvant trastuzumab improves survival in early breast cancer
    Brower, Vicki
    [J]. LANCET ONCOLOGY, 2014, 15 (13): : E589 - E589
  • [6] Adjuvant Trastuzumab Treatment without Adjuvant Chemotherapy in Early Breast Cancer
    Dall, P.
    Koch, T.
    Lenzen, G.
    Kuhn, T.
    Hielscher, C.
    Reichert, D.
    Maasberg, M.
    Ehscheidt, P.
    Eustermann, H.
    Fischer, G.
    [J]. CANCER RESEARCH, 2011, 71
  • [7] Cost-Effectiveness of Trastuzumab as Adjuvant Therapy for Early Breast Cancer: A Systematic Review
    Chan, Agnes L. F.
    Leung, Henry W. C.
    Lu, Chin-Li
    Lin, Shun Jin
    [J]. ANNALS OF PHARMACOTHERAPY, 2009, 43 (02) : 296 - 303
  • [8] Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK
    Earl, H. M.
    Hiller, L.
    Dunn, J.
    Macpherson, I.
    Rea, D.
    Hughes-Davies, L.
    McAdam, K.
    Hall, P.
    Mansi, J.
    Wheatley, D.
    Abraham, J. E.
    Caldas, C.
    Gasson, S.
    O'Riordan, E.
    Wilcox, M.
    Miles, D.
    Cameron, D. A.
    Wardley, A.
    [J]. CLINICAL ONCOLOGY, 2021, 33 (01) : 15 - 19
  • [9] Sudden death during adjuvant trastuzumab therapy of breast cancer
    Oliveira, M.
    Nave, M.
    Gil, N.
    Passos-Coelho, J. L.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (04)
  • [10] Role of trastuzumab in adjuvant therapy for locally invasive breast cancer
    Kabe, KL
    Kolesar, JM
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (06) : 527 - 533
12345